1-4 of 4
Wijnand Helfrich
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4553: A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint

Iris Koopmans, Douwe F. Samplonius, Robert J. van Ginkel, Peter J. Wierstra, Sandra Heskamp, Edwin Bremer, Wijnand Helfrich
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 4553.
https://doi.org/10.1158/1538-7445.AM2018-4553
Published: 01 July 2018
View article titled, Abstract 4553: A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint
Journal Articles

Pretargeted Dual-Modality Immuno-SPECT and Near-Infrared Fluorescence Imaging for Image-Guided Surgery of Prostate Cancer

Susanne Lütje, Mark Rijpkema, David M. Goldenberg, Catharina M. van Rij, Robert M. Sharkey, William J. McBride, Gerben M. Franssen, Cathelijne Frielink, Wijnand Helfrich, Wim J.G. Oyen, Otto C. Boerman
Journal: Cancer Research
Cancer Res (2014) 74 (21): 6216–6223.
https://doi.org/10.1158/0008-5472.CAN-14-0594
Published: 30 October 2014
View article titled, Pretargeted Dual-Modality Immuno-SPECT and Near-Infrared Fluorescence Imaging for Image-Guided Surgery of Prostate Cancer
Open the PDF for Pretargeted Dual-Modality Immuno-SPECT and Near-Infrared Fluorescence Imaging for Image-Guided Surgery of Prostate Cancer in another window
Journal Articles

Superior Activity of Fusion Protein scFvRit:sFasL over Cotreatment with Rituximab and Fas Agonists

Edwin Bremer, Bram ten Cate, Douwe F. Samplonius, Nicole Mueller, Harald Wajant, Alja J. Stel, Martine Chamuleau, Arjan A. van de Loosdrecht, Julia Stieglmaier, Georg H. Fey, Wijnand Helfrich
Journal: Cancer Research
Cancer Res (2008) 68 (2): 597–604.
https://doi.org/10.1158/0008-5472.CAN-07-5171
Published: 15 January 2008
View article titled, Superior Activity of Fusion Protein scFvRit:sFasL over Cotreatment with Rituximab and Fas Agonists
Open the PDF for Superior Activity of Fusion Protein scFvRit:sFasL over Cotreatment with Rituximab and Fas Agonists in another window
Journal Articles

Target Cell–Restricted Apoptosis Induction of Acute Leukemic T Cells by a Recombinant Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Fusion Protein with Specificity for Human CD7

Edwin Bremer, Douwe F. Samplonius, Matthias Peipp, Linda van Genne, Bart-Jan Kroesen, Georg H. Fey, Martin Gramatzki, Lou F.M.H. de Leij, Wijnand Helfrich
Journal: Cancer Research
Cancer Res (2005) 65 (8): 3380–3388.
https://doi.org/10.1158/0008-5472.CAN-04-2756
Published: 15 April 2005
View article titled, Target Cell–Restricted Apoptosis Induction of Acute Leukemic T Cells by a Recombinant Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Fusion Protein with Specificity for Human CD7
Open the PDF for Target Cell–Restricted Apoptosis Induction of Acute Leukemic T Cells by a Recombinant Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Fusion Protein with Specificity for Human CD7 in another window